Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Hepatitis B (HBV) Clinical Research Samples
Discovery Life Sciences provides the highest quality Hepatitis B (HBV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Hepatitis B (HBV) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 173 of 173 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Detail 3 | Product Details | Price | Buy | Blood Type | Symptoms | ICD10 codes | Date of Freeze | Initial Date of Diagnosis | Additional Testing | Co-Infections | 3-series HepB Vaccine | Is Subject on Anti-Viral Therapy / Treatment | Acquired Infection Category | Hepatitis Serology | Roche Cobas | Aptima HBV Quant Assay | Sample Test Date | Treatment Status | 3- Series HepB Vaccine | Acquired Infections Category | HBV Ct Value | HBsAg Titer | Prism | Elisa | Confirmation | Additional Results | DGV | Mutation | DGV Ultrio | Axsym | Evolis | Elisa 2 | Mutation | Serotype | Procleix Ultrio Assay Novartis | Cobas Taqman HBV test | Titer Ag HBs | HBc Result | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBS0000-AI900108405013019DD | Hepatitis B (HBV) | USA | 2.00 | 1.00 | $75.00 | 60 Y | Male | <-70C | 30-Jan-19 | Abbott Architect | 7,504 | HBV | $75.00 | Unknown | 05.21.19 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900205218100819DD | Hepatitis B (HBV) | Serum | 1.30 | 1.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 08-Oct-19 | COBAS(R) AmpliPrep | TaqMan(R) HBV Test v2.0 | 163 | HBV | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900205452102919DD | Hepatitis B (HBV) | Serum | 1.30 | 1.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 29-Oct-19 | COBAS(R) AmpliPrep | TaqMan(R) HBV Test v2.0 | 3,176 | HBV | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900338172102919DD | Hepatitis B (HBV) | Serum | 1.10 | 1.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 29-Oct-19 | COBAS(R) AmpliPrep | TaqMan(R) HBV Test v2.0 | 3,176 | HBV | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900338499102219DD | Hepatitis B (HBV) | Serum | 1.20 | 1.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 22-Oct-19 | COBAS(R) AmpliPrep | TaqMan(R) HBV Test v2.0 | 164 | HBV | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AU900099421020519DD | Hepatitis B (HBV) | USA | 1.00 | 1.00 | $75.00 | 34 Y | Female | <-70C | 05-Feb-19 | PCR | Bioplex | 3,745 IU/mL | HBV | $75.00 | Unknown | D25.1, Z01.411, O98.419, O34.29, O82, R10.9, Z86.32, K80.20, K82.8, B18.1, N73.9 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AU900105156052118DD | Hepatitis B (HBV) | USA | 1.50 | 1.00 | $75.00 | 59 Y | Female | <-70C | 21-May-18 | PCR | Bioplex | 87 IU/mL | HBV DNA Viral Load | $75.00 | Unknown | B19.10, E66.9, E55.9, I10 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-CV900103646060518DD | Hepatitis B (HBV) | Vietnam | 1.00 | 3.00 | $200.00 | 48 Y | Male | <-70C | 05-Jun-18 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 28-May-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 2010 | ALT: 544 U/L | AST: 834 U/L | Bilirubin: 39 umol/L | Creatinine: 68 umol/L | Chronic Hepatitis B 28-May-18 | None | ||||||||||||||||||||||||||||||||||||||
| BBS0000-CV900103648012618DD | Hepatitis B (HBV) | Vietnam | 1.00 | 1.00 | $200.00 | 37 Y | Male | <-70C | 26-Jan-18 | Roche Cobas Taqman | 18,100 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 16-Jan-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 16-Jan-18 | ALT: 900 U/L | AST: 1500 U/L | Bilirubin: 328.7 umol/L | Creatinine: 80 umol/L | Chronic Hepatitis B 11-Jan-18 | None | ||||||||||||||||||||||||||||||||||||||
| BBS0000-CV900106870073114DD | Hepatitis B (HBV) | Vietnam | 1.00 | 3.00 | $200.00 | 41 Y | Male | < -70C | 31-Jul-14 | Aptima HBV Quant Assay | 6,423 IU/mL | 21-Jun-16 | Real-Time PCR | C | 1-Aug-14 | Aptima HBV Quant Assay | 3.81 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Fatigue; Jaundice | None | No | No | U/A | HBsAg +; Anti HCV + (Elisa) 20-Jun-14 | |||||||||||||||||||||||||||||||||
| BBS0005-AU900020881052118DD | Hepatitis B (HBV) | USA | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 31 Y | Female | Non-Hispanic | <-70C | 21-May-18 | PCR | Bioplex | 5,357 IU/mL | HBV DNA Viral Load | $75.00 | Unknown | B18.1 | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AU900020882052118DD | Hepatitis B (HBV) | USA | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 38 Y | Female | Non-Hispanic | <-70C | 21-May-18 | PCR | Bioplex | 6,241 IU/mL | HBV DNA Viral Load | $75.00 | Unknown | N94.6, N92.6, B18.1, A60.00, D25.1, D25.9, O42.90, O03.9, O36.4XX0, E66.9 | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AU900030829040119DD | Hepatitis B (HBV) | USA | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 44 Y | Male | Non-Hispanic | <-70C | 01-Apr-19 | PCR | Bioplex | 87 IU/mL | HBV DNA | $75.00 | Unknown | B19.20, B19.10, K72.90, F19.10 | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AU900031287042619DD | Hepatitis B (HBV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 55 Y | Male | Non-Hispanic | <-70C | 26-Apr-19 | Bioplex PCR | 182 IU/mL | HBV DNA | $75.00 | Unknown | K21.9, Z79.01, Z95.2, Z98.890, R91.8, E78.00, N18.9, R80.9, I50.9, M10.9, M32.14, N18.3, E21.1, I15.1, Z79.899, M25.551 | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AU900031318050719DD | Hepatitis B (HBV) | USA | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 35 Y | Female | Non-Hispanic | <-70C | 07-May-19 | PCR | Bioplex | 525 IU/mL | HBV | $75.00 | Unknown | Z34.03, O09.893, O98.419, O42.90, O70.1, O80 | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AU900031324061619DD | Hepatitis B (HBV) | USA | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 65 Y | Male | Non-Hispanic | <-70C | 16-Jun-19 | PCR | Bioplex | 210 IU/mL | HBV DNA Viral Load | $75.00 | Unknown | K75.81, I82.890, E11.9, Z79.01, E11.65, J32.9, J33.9, J34.2, J32.4, Z94.4, Z29.8, E66.9, E44.1, B19.10 | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AU900031811040518DD | Hepatitis B (HBV) | USA | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 65 Y | Female | Non-Hispanic | <-70C | 05-Apr-18 | PCR | Bioplex | 88 IU/mL | HBV DNA Viral Load | $75.00 | Unknown | B18.1, G47.33, M15.2, G56.02, M85.80 | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AU900079998052118DD | Hepatitis B (HBV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 50 Y | Female | Non-Hispanic | <-70C | 21-May-18 | PCR | Bioplex | 554 IU/mL | HBV DNA Viral Load | $75.00 | Unknown | B18.1, B18.2 | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AU900079999052218DD | Hepatitis B (HBV) | USA | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 26 Y | Female | Non-Hispanic | <-70C | 22-May-18 | PCR | Bioplex | 6,473 IU/mL | HBV DNA Viral Load | $75.00 | Unknown | H52.10, R76.11, M67.40, O0001, N80.1, D25.2, G43.009, O98.411, O34.10, D25.9, Z34.90, O80 | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900023305123014DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 34 Y | Male | Non-Hispanic | < -70C | 30-Dec-14 | Aptima HBV Quant Assay | 42,336 IU/mL | 21-Jun-16 | Real-Time PCR | C | 31-Dec-14 | Aptima HBV Quant Assay | 4.63 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | ALT: 197 U/L; AST: 210 U/L; Bilirubin: 87 umol/L; Serum Creatinine: 0.8 mg/dL 19-Dec-14 | No | No | U/A | None | |||||||||||||||||||||||||||||||
| BBS0005-CV900029054041718DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 51 Y | Female | Non-Hispanic | <-70C | 17-Apr-18 | Roche Cobas Taqman | 3,390 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 27-Mar-18 | $200.00 | Unknown | Fatigue; Fever | 2018 | ALT: 2108 U/L | AST: 1668 U/L | Bilirubin: 126.6 umol/L | Creatinine: 55 umol/L | Acute Hepatitis B 23-Mar-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900029056030918DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 57 Y | Female | Non-Hispanic | <-70C | 09-Mar-18 | Roche Cobas Taqman | 4,660 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 28-Feb-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 18-Feb | ALT: 86 U/L | AST: 69 U/L | Bilirubin: 42.9 umol/L | Creatinine: 62 umol/L | Chronic Hepatitis B 8-Mar-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900029068042418DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 46 Y | Female | Non-Hispanic | <-70C | 24-Apr-18 | Roche Cobas Taqman | 57,600,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBeAb + ;HBeAg + ; | 17-Apr-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 2008 | ALT: 1075 U/L | AST: 740 U/L | Bilirubin: 15.6 umol/L | Creatinine: 59 umol/L | Chronic Hepatitis B 10-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900029069042418DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 33 Y | Male | Non-Hispanic | <-70C | 24-Apr-18 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; HBeAb + ; HBeAg - ; | 19-Apr-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 2012 | ALT: 48 U/L | AST: 34 U/L | Bilirubin: 4.9 umol/L | Creatinine: 85 umol/L | Chronic Hepatitis B 9-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900036011120915DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 32 Y | Female | Non-Hispanic | <-70C | 09-Dec-15 | Roche cobas | 6,790,000 IU/mL | HBV PCR | $200.00 | Unknown | Fatigue | ALT: 715 U/L, AST: 349 U/L, Bilirubin: 7.6 umol/L, Creatinine: 75 umol/L 28-Nov-15 | No | No | Unknown | None | |||||||||||||||||||||||||||||||||||||
| BBS0005-CV900036018082815DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 36 Y | Male | Non-Hispanic | <-70C | 28-Aug-15 | Aptima HBV Quant Assay | 7,509 IU/mL | 21-Jun-16 | Real-Time PCR | C | 10-Sep-15 | Aptima HBV Quant Assay | 3.88 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Fatigue | N/A | No | No | U/A | N/A | |||||||||||||||||||||||||||||||
| BBS0005-CV900036172061814DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 54 Y | Male | Non-Hispanic | < -70C | 18-Jun-14 | Aptima HBV Quant Assay | 11,900 IU/mL | 21-Jun-16 | Real-Time PCR | C | Aptima HBV Quant Assay | 4.08 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Abdominal pain; Jaundice; Itching; Sleep disturbances | ALT: 1766; AST: 1659; Bilirubin: 176 umol/L; Serum Creatinine: 0.8 mg/dL | No | No | U/A | N/A | ||||||||||||||||||||||||||||||||
| BBS0005-CV900036174091614DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 29 Y | Female | Non-Hispanic | < -70C | 16-Sep-14 | Roche cobas | 26,100 IU/mL | HBV PCR | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | ALT: 166; AST: 175; Bilirubin: 146 umol/L; Serum Creatinine: 0.6 mg/dL 9-Sep-14 | No | No | Unknown | HBsAg + (Cobas) 28-Aug-14 | Positive 13-Mar-18 | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900036179081314DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 38 Y | Female | Non-Hispanic | < -70C | 13-Aug-14 | Aptima HBV Quant Assay | 222,377 IU/mL | 21-Jun-16 | Real-Time PCR | C | 14-Aug-14 | Aptima HBV Quant Assay | 5.35 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Fatigue; Abdominal pain; Jaundice | ALT: 421; AST: 644; Bilirubin: 25.3 umol/L; Serum Creatinine: 0.74 mg/dL 16-Jul-14 | No | No | U/A | N/A | |||||||||||||||||||||||||||||||
| BBS0005-CV900040659011918DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 5.00 | $200.00 | 45 Y | Male | Non-Hispanic | <-70C | 19-Jan-18 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 9-Jan-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 9-Jan-18 | ALT: 300 U/L | AST: 673 U/L | ALP: 101 U/L | Bilirubin: 21.3 umol/L | Creatinine: 87 umol/L | Chronic Hepatitis B 9-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900040660031418DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 42 Y | Male | Non-Hispanic | <-70C | 14-Mar-18 | Roche Cobas Taqman | 4,210 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 9-Mar-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 2008 | ALT: 361 U/L | AST: 192 U/L | Bilirubin: 513 umol/L | Creatinine: 72 umol/L | Cirrhosis and Hepatitis B 6-Mar-18 | Cirrhosis | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900040671041718DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.25 | 5.00 | $200.00 | 37 Y | Male | Non-Hispanic | <-70C | 17-Apr-18 | Roche Cobas Taqman | 31,600,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 7-Apr-18 | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | 2014 | ALT: 317 U/L | AST: 139 U/L | Bilirubin: 163 umol/L | Creatinine: 102 umol/L | Chronic Hepatitis B 7-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900047656061214DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 20 Y | Male | Non-Hispanic | < -70C | 12-Jun-14 | Aptima HBV Quant Assay | 1,078 IU/mL | 21-Jun-16 | Real-Time PCR | C | Aptima HBV Quant Assay | 3.03 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Abdominal pain; Jaundice; Itching | ALT: 267; AST: 237; Bilirubin: 199 umol/L; Serum Creatinine: 1.0 mg/dL | No | No | U/A | N/A | ||||||||||||||||||||||||||||||||
| BBS0005-CV900048147122717DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 51 Y | Male | Non-Hispanic | <-70C | 27-Dec-17 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 20-Dec-17 | $200.00 | Unknown | Fatigue; Jaundice | 20-Dec-17 | ALT: 227 U/L | AST: 412 U/L | ALP: 160 U/L | Bilirubin: 28.2 umol/L | Creatinine: 87 umol/L | Chronic Hepatitis B 20-Dec-17 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900048151122717DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 71 Y | Female | Non-Hispanic | <-70C | 27-Dec-17 | Roche Cobas Taqman | 911,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 23-Dec-17 | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue | 2010 | ALT: 193 U/L | AST: 140 U/L | Bilirubin: 12.8 umol/L | Creatinine: 60 umol/L | Chronic Hepatitis B 23-Dec-17 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900049295041918DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 60 Y | Male | Non-Hispanic | <-70C | 19-Apr-18 | Roche Cobas Taqman | 170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; HBeAg - ; HBcIgM - | 29-Mar-18 | $200.00 | Unknown | Fatigue | 10-Mar-18 | ALT: 877 U/L | AST: 1094 U/L | Bilirubin: 135 umol/L | Creatinine: 69 umol/L | Chronic Hepatitis B 13-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900049296042418DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 50 Y | Male | Non-Hispanic | <-70C | 24-Apr-18 | Roche Cobas Taqman | 1,020 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 16-Apr-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 2000 | ALT: 142 U/L | AST: 281 U/L | Bilirubin: 388 umol/L | Creatinine: 57 umol/L | Chronic Hepatitis B 2-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900049298042418DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 43 Y | Male | Non-Hispanic | <-70C | 24-Apr-18 | Roche Cobas Taqman | 3,020,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBeAb + ; HBeAg + HBc Total + ; HBcIgM - ; | 20-Apr-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 2011 | ALT: 1167 U/L | AST: 334 U/L | Bilirubin: 382 umol/L | Creatinine: 74 umol/L | Chronic Hepatitis B 1-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900049299031418DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 35 Y | Male | Non-Hispanic | <-70C | 14-Mar-18 | Roche Cobas Taqman | 363,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; | 9-Mar-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 2001 | ALT: 676 U/L | AST: 1184 U/L | Bilirubin: 274 umol/L | Creatinine: 81 umol/L | Chronic Hepatitis B 8-Mar-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900049300041718DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 68 Y | Male | Non-Hispanic | <-70C | 17-Apr-18 | Roche Cobas Taqman | 168,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAb + ; 3-Apr-2018 ; Anti HBe + ; | 3-Apr-2018 | 9-Apr-2018 | $200.00 | Unknown | Decreased appetite; Fatigue | 3-Apr-18 | ALT: 70 U/L | AST: 109 U/L | Bilirubin: 39.6 umol/L | Creatinine: 96 umol/L | Chronic Hepatitis B 3-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900052435061214DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 43 Y | Male | Non-Hispanic | < -70C | 12-Jun-14 | Aptima HBV Quant Assay | 6,670 IU/mL | 21-Jun-16 | Real-Time PCR | C | Aptima HBV Quant Assay | 3.82 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Sleep disturbances | ALT: 227; AST: 367; Bilirubin: 21.8 umol/L; Serum Creatinine: 0.8 mg/dL | No | No | U/A | N/A | ||||||||||||||||||||||||||||||||
| BBS0005-CV900052438061314DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 46 Y | Female | Non-Hispanic | < -70C | 13-Jun-14 | Roche cobas | 2,580 cps/mL | HBV PCR | $200.00 | Unknown | Decreased appetite; Fatigue; Abdominal pain; Itching; Depression | ALT: 57; AST: 26; Bilirubin: 48.9 umol/L; Serum Creatinine: 1.02 mg/dL | No | No | Unknown | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900054340031418DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 5.00 | $200.00 | 31 Y | Male | Non-Hispanic | <-70C | 14-Mar-18 | Roche Cobas Taqman | 1,580,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; | 8-Mar-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 8-Mar-18 | ALT: 802 U/L | AST: 1041 U/L | Bilirubin: 49 umol/L | Creatinine: 45 umol/L | Acute Hepatitis B 8-Mar-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900054611011315DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 56 Y | Male | Non-Hispanic | < -70C | 13-Jan-15 | Aptima HBV Quant Assay | 341,051 IU/mL | 21-Jun-16 | Real-Time PCR | C | 22-Jan-15 | Aptima HBV Quant Assay | 5.53 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Jaundice; Flu-like Symptoms | ALT: 118 U/L; AST: 31 U/L; Bilirubin: 30.6 umol/L; Serum Creatinine: 1.2 mg/dL 4,5-Jan-2014 | Partial | No | U/A | HBsAg + (Cobas) 5-Jan-14 | Positive 13-Mar-18 | ||||||||||||||||||||||||||||||
| BBS0005-CV900054751061814DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 43 Y | Female | Non-Hispanic | < -70C | 18-Jun-14 | Aptima HBV Quant Assay | 176,599 IU/mL | 21-Jun-16 | Real-Time PCR | C | Aptima HBV Quant Assay | 5.25 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Abdominal pain; Jaundice | ALT: 48; AST: 27; Bilirubin: 19.2 umol/L; Serum Creatinine: 0.6 mg/dL | No | No | U/A | N/A | ||||||||||||||||||||||||||||||||
| BBS0005-CV900054756071014DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 49 Y | Male | Non-Hispanic | < -70C | 10-Jul-14 | Aptima HBV Quant Assay | 1,542 IU/mL | 21-Jun-16 | Real-Time PCR | C | Aptima HBV Quant Assay | 3019 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | ALT: 225; AST: 889; ALP: 188; Serum Creatinine: 0.7 mg/dL; Bilirubin: 108 umol/L | No | No | U/A | N/A | ||||||||||||||||||||||||||||||||
| BBS0005-CV900054758062414DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 59 Y | Male | Non-Hispanic | < -70C | 24-Jun-14 | Aptima HBV Quant Assay | 4,885 IU/mL | 21-Jun-16 | Real-Time PCR | C | Aptima HBV Quant Assay | 3.69 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice; Sleep disturbances | ALT: 1263; AST: 1810; ALP: 185; Bilirubin: 365.8 umol/L; Serum Creatinine: 0.75 mg/dL | No | No | U/A | HBsAg+ (Elisa) | Positive 13-Mar-18 | |||||||||||||||||||||||||||||||
| BBS0005-CV900056406060418DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 30 Y | Male | Non-Hispanic | <-70C | 04-Jun-18 | Roche Cobas Taqman | 5,050,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 23-May-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 2016 | ALT: 2355 U/L | AST: 1514 U/L | Bilirubin: 93.6 umol/L | Creatinine: 71 umol/L | Hepatitis B 23-May-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900056407012618DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 62 Y | Male | Non-Hispanic | <-70C | 26-Jan-18 | Roche Cobas Taqman | 102,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 18-Jan-18 | $200.00 | Unknown | Jaundice | 18-Jan-18 | ALT: 104 U/L | AST: 272 U/L | Bilirubin: 173 umol/L | Creatinine: 53 umol/L | Chronic Hepatitis B 18-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900056408012618DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 59 Y | Male | Non-Hispanic | <-70C | 26-Jan-18 | Roche Cobas Taqman | 37,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 19-Jan-18 | $200.00 | Unknown | Abdominal pain; Fatigue | 2016 | ALT: 3350 U/L | AST: 1762 U/L | Bilirubin: 61.1 umol/L | Creatinine: 98 umol/L | Chronic Hepatitis B 19-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900056781070215DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 50 Y | Male | Non-Hispanic | <-70C | 02-Jul-15 | Aptima HBV Quant Assay | 225,982 IU/mL | 21-Jun-16 | Real-Time PCR | C | 9-Jul-15 | Aptima HBV Quant Assay | 5.35 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | N/A | No | No | U/A | N/A | |||||||||||||||||||||||||||||||
| BBS0005-CV900056782111815DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 29 Y | Male | Non-Hispanic | <-70C | 18-Nov-15 | Aptima HBV Quant Assay | 208,990 IU/mL | 21-Jun-16 | Real-Time PCR | C | 26-Nov-15 | Aptima HBV Quant Assay | 5.32 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | N/A | No | No | U/A | N/A | |||||||||||||||||||||||||||||||
| BBS0005-CV900062660012618DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 30 Y | Female | Non-Hispanic | <-70C | 26-Jan-18 | Roche Cobas Taqman | 1,240,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 17-Jan-18 | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue | 17-Jan-18 | ALT: 337 U/L | AST: 490 U/L | Bilirubin: 14 umol/L | Creatinine: 73 umol/L | Chronic Hepatitis B 17-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900062661011018DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 31 Y | Male | Non-Hispanic | <-70C | 10-Jan-18 | Roche Cobas Taqman | 313,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 2-Jan-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 2-Jan-18 | ALT: 153 U/L | AST: 503 U/L | Bilirubin: 17.3 umol/L | Creatinine: 75 umol/L | Acute Hepatitis B 4-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900062663122917DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 54 Y | Male | Non-Hispanic | <-70C | 29-Dec-17 | Roche Cobas Taqman | 3,300,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 25-Dec-17 | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue | 2000 | ALT: 59 U/L | AST: 126 U/L | Bilirubin: 431.4 umol/L | Creatinine: 95 umol/L | Hepatitis B 25-Dec-17 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900062669080218DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 0.90 | 4.00 | $200.00 | 33 Y | Male | Non-Hispanic | <-70C | 02-Aug-18 | Roche Cobas Taqman | 4,170,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 28-Jun-18 | $200.00 | Unknown | Abdominal pain; Fatigue | 18-Jun | ALT: 537 U/L | AST: 107 U/L | Bilirubin: 13.2 umol/L | Creatinine: 62 umol/L | Chronic Hepatitis B 30-Jun-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900066836060518DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 42 Y | Male | Non-Hispanic | <-70C | 05-Jun-18 | Roche Cobas Taqman | 556,000 IU/mL | HBV DNA | Hepatitis Serology Result | HCV Ab + ; HBsAg + | 17-May-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 17-May-18 | ALT: 227 U/L | AST: 114 U/L | Bilirubin: 117 umol/L | Creatinine: 73 umol/L | Hepatitis B and C 25-May-18 | HCV Ab+ ; HCV RNA- | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900066838011918DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 70 Y | Female | Non-Hispanic | <-70C | 19-Jan-18 | Roche Cobas Taqman | 97,200 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 15-Jan-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 1998 | ALT: 227 U/L | AST: 186 U/L | Bilirubin: 10.9 umol/L | Creatinine: 66 umol/L | Chronic Hepatitis B 18-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900066841080318DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 59 Y | Male | Non-Hispanic | <-70C | 03-Aug-18 | Roche Cobas Taqman | 737,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 27-Jul-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 2014 | ALT: 54 U/L | AST: 105 U/L | Bilirubin: 71.4 umol/L | Creatinine: 179 umol/L | Chronic Hepatitis B 26-Jul-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900066909071014DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 60 Y | Female | Non-Hispanic | < -70C | 10-Jul-14 | Aptima HBV Quant Assay | 918,157 IU/mL | 21-Jun-16 | Real-Time PCR | C | 18-Jul-14 | Aptima HBV Quant Assay | 5.96 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Abdominal pain; Depression | ALT: 116; AST: 52; Bilirubin: 126.7 umol/L; Serum Creatinine: 0.7 mg/dL 4-Jul-14 | No | No | U/A | N/A | |||||||||||||||||||||||||||||||
| BBS0005-CV900068564100515DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 31 Y | Male | Non-Hispanic | <-70C | 05-Oct-15 | Aptima HBV Quant Assay | 22,353 IU/mL | 21-Jun-16 | Real-Time PCR | C | 8-Oct-15 | Aptima HBV Quant Assay | 4.35 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | N/A | No | No | U/A | N/A | |||||||||||||||||||||||||||||||
| BBS0005-CV900071815052215DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 6.00 | $200.00 | 54 Y | Male | Non-Hispanic | <-70C | 22-May-15 | Roche cobas | 1,930 IU/mL | HBV PCR | $200.00 | Unknown | Decreased appetite; Fatigue | No | No | Unknown | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900071817123114DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 36 Y | Female | Non-Hispanic | < -70C | 31-Dec-14 | Aptima HBV Quant Assay | 14,773 IU/mL | 21-Jun-16 | Real-Time PCR | C | 22-Jan-15 | Aptima HBV Quant Assay | 4.17 Log IU/mL | 21-Jun-16 | $200.00 | Unknown | Decreased appetite; Jaundice | ALT: 343 U/L; AST: 335 U/L; Bilirubin: 71.6 umol/L; Serum Creatinine: 59 umol/L 15-Dec-14 | No | No | U/A | None | |||||||||||||||||||||||||||||||
| BBS0005-CV900074040122717DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 34 Y | Male | Non-Hispanic | <-70C | 27-Dec-17 | Roche Cobas Taqman | 43,900 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 9-Nov-17 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 9-Nov-17 | ALT: 89 U/L | AST: 127 U/L | Bilirubin: 127 umol/L | Creatinine: 60 umol/L | Hepatitis B 26-Dec-17 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900074053080218DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 41 Y | Male | Non-Hispanic | <-70C | 02-Aug-18 | Roche Cobas Taqman | 3,250,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 13-Jul-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 13-Jul-18 | ALT: 138 U/L | AST: 25 U/L | Bilirubin: 200 umol/L | Creatinine: 67 umol/L | Chronic Hepatitis B 25-Jul-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077135052215DD | Hepatitis B (HBV) | Vietnam | 1.00 | 1.00 | $200.00 | 36 Y | Male | <-70C | 22-May-15 | Roche cobas | 12,900 IU/mL | HBV PCR | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | No | No | Unknown | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077150060815DD | Hepatitis B (HBV) | Vietnam | 1.00 | 3.00 | $200.00 | 25 Y | Male | <-70C | 08-Jun-15 | Roche cobas | 3,250 IU/mL | HBV PCR | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | No | No | Unknown | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077152010715DD | Hepatitis B (HBV) | Vietnam | 1.00 | 1.00 | $200.00 | 34 Y | Female | < -70C | 07-Jan-15 | Roche cobas | 35,800 IU/mL | HBV PCR | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | ALT: 77 U/L; AST: 82 U/L; Bilirubin: 251.5 umol/L; Serum Creatinine: 0.6 mg/dL 6-Jan-15 | No | No None | Unknown | None | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077905052518DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 28 Y | Male | Non-Hispanic | <-70C | 25-May-18 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBeAg +; HBeAb - | 23-May-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 2014 | ALT: 657 U/L | AST: 343 U/L | Bilirubin: 86 umol/L | Creatinine: 82 umol/L | Chronic Hepatitis B 21-May-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077908012618DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 78 Y | Male | Non-Hispanic | <-70C | 26-Jan-18 | Roche Cobas Taqman | 651,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 19-Jan-18 | $200.00 | Unknown | Abdominal pain; Dark urine; Jaundice | 17-Feb | ALT: 82 U/L | AST: 34 U/L | Bilirubin: 68 umol/L | Creatinine: 269 umol/L | Chronic Hepatitis B 25-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077909122717DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 34 Y | Male | Non-Hispanic | <-70C | 27-Dec-17 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 2003 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 2003 | ALT: 881 U/L | AST: 606 U/L | Bilirubin: 140.4 umol/L | Creatinine: 72 umol/L | Chronic Hepatitis B 22-Dec-17 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077910031418DD | Hepatitis B (HBV) | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 68 Y | Male | Non-Hispanic | <-70C | 14-Mar-18 | Roche Cobas Taqman | 74,400 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 9-Mar-18 | $200.00 | Unknown | Fatigue; Jaundice | 1998 | ALT: 418 U/L | AST: 269 U/L | Bilirubin: 20.6 umol/L | Creatinine: 99 umol/L | Chronic Hepatitis B 8-Mar-18 | None | ||||||||||||||||||||||||||||||||||||
| BBS0005-EN900073214111715DD | Hepatitis B (HBV) | Italy | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 53 Y | Male | Unknown | <-70C | 17-Nov-15 | Roche cobas | 229 IU/mL | HBV PCR | Roche Cobas | Positive | 13-Mar-18 | $200.00 | Unknown | None | No | No | No | HBsAg+ , HCV Ab- , HDV Ab- | |||||||||||||||||||||||||||||||||||
| BBS0005-ER900068508040114DD | Hepatitis B (HBV) | Germany | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 30 Y | Female | Unknown | < -70C | 01-Apr-14 | Gene S Sequencing In-house Assay | 45 IU/mL | HBV PCR | $200.00 | Unknown | Fatigue | No | No | Unknown | HBsAg+ (CMIA) | ||||||||||||||||||||||||||||||||||||||
| CIT0000-A0900112335092008DD | Hepatitis B (HBV) | South Africa | Citrated Plasma | 1.00 | 110.00 | $75.00 | 25 Y | Male | Non-Hispanic | <-70C | 20-Sep-08 | Murex | Positive | HBV IgM | S/CO | 0.135 | OD Value | 4.012 | $75.00 | Unknown | None | Apparently Healthy | 27-Sep-08 | Newly Diagnosed | ||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032215021608DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.50 | 1.00 | $75.00 | 33 Y | Male | Unknown | < -70C | 16-Feb-08 | Roche cobas | 495 IU/mL | HBV Ct Value - 28 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | N/A | HBsAG S/Co (483) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036023112806DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 41 Y | Female | Unknown | <-70°C | 28-Nov-06 | Roche cobas | 2,082 IU/mL | HBV Ct Value - 29 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co+ (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott IMX) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036024082307DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 43 Y | Male | Unknown | <-70°C | 23-Aug-07 | Roche cobas | 83 IU/mL | HBV Ct Value - 31 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co+ (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott IMX) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036738122106DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.50 | 1.00 | $75.00 | 27 Y | Male | Unknown | < -70C | 21-Dec-06 | Roche cobas | 588 IU/mL | HBV Ct Value - 30 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | N/A | HBsAG S/Co (417) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036739122406DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 42 Y | Female | Unknown | < -70C | 24-Dec-06 | Roche cobas | 106 IU/mL | HBV Ct Value - 31 | Innogenetics INNO-LIPA | A | 3-series HepB Vaccine | N/A | $75.00 | Unknown | Asymptomatic | N/A | No | N/A | HBsAG S/Co (304) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | ||||||||||||||||||||||||||||||||||
| CIT0000-CS900036740011711DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 0.50 | 1.00 | $75.00 | 63 Y | Female | Unknown | < -70C | 17-Jan-11 | Roche cobas | 164 IU/mL | HBV Ct Value - 27 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | No | N/A | HBsAG S/Co (355) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | N/A | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036741120310DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 28 Y | Male | Unknown | < -70C | 03-Dec-10 | Roche cobas | 430 IU/mL | HBV Ct Value - 29 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | HBsAG S/Co (466) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | N/A | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036742111012DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 27 Y | Male | Unknown | < -70C | 10-Nov-12 | Roche cobas | 32 IU/mL | HBV Ct Value - 29 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | N/A | HBsAG S/Co (531.27) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036743020912DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 0.75 | 1.00 | $75.00 | 33 Y | Male | Unknown | < -70C | 09-Feb-12 | Roche cobas | 314 IU/mL | HBV Ct Value - 29 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | N/A | HBsAG S/Co (524) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036744041111DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 56 Y | Female | Unknown | < -70C | 11-Apr-11 | Roche cobas | 76 IU/mL | HBV Ct Value - 28 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | N/A | HBsAG S/Co (253) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036745011112DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 42 Y | Male | Unknown | < -70C | 11-Jan-12 | Roche cobas | 42 IU/mL | HBV Ct Value - 31 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | HBsAG S/Co (252) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | N/A | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900036746040811DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 0.75 | 1.00 | $75.00 | 38 Y | Female | Unknown | < -70C | 08-Apr-11 | Roche cobas | 98 IU/mL | Innogenetics INNO-LIPA | F | $75.00 | Unknown | Asymptomatic | No | HBsAG S/Co (454) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | 27 | ||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036747062511DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.50 | 1.00 | $75.00 | 47 Y | Male | Unknown | < -70C | 25-Jun-11 | Roche cobas | 381 IU/mL | HBV Ct Value - 27 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | N/A | HBsAG S/Co (312) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900039255011113DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 0.75 | 1.00 | $75.00 | 44 Y | Female | Unknown | < -70C | 11-Jan-13 | Roche cobas | 156 IU/mL | HBV Ct Value - 30 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | N/A | HBsAG S/Co (485) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900039256021407DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 50 Y | Female | Unknown | < -70C | 14-Feb-07 | Roche cobas | 61 IU/mL | HBV Ct Value - 29 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | N/A | HBsAG S/Co (272) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900039257112006DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 53 Y | Male | Unknown | < -70C | 20-Nov-06 | Roche cobas | 971 IU/mL | HBV Ct Value - 26 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | No | N/A | HBsAG S/Co (224) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900041719091612DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 0.25 | 1.00 | $75.00 | 46 Y | Male | Unknown | <-70°C | 16-Sep-12 | Roche cobas | 423 IU/mL | HBV Ct Value - 30 | Innogenetics INNO-LIPA | A | 3-series HepB Vaccine | N/A | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | HBsAG S/Co (533) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | ||||||||||||||||||||||||||||||||||
| CIT0000-CS900041720092912DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 0.75 | 1.00 | $75.00 | 30 Y | Male | Unknown | <-70°C | 29-Sep-12 | Roche cobas | 499 IU/mL | HBV Ct Value - 31 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (495) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900041721100512DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.25 | 1.00 | $75.00 | 29 Y | Male | Unknown | <-70°C | 05-Oct-12 | Roche cobas | 502 IU/mL | HBV Ct Value - 29 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (570) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900041722101012DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 0.25 | 1.00 | $75.00 | 50 Y | Male | Unknown | <-70°C | 10-Oct-12 | Roche cobas | Not Detected | HBV Ct Value - 34 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (542) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||
| CIT0000-CS900066333110312DD | Hepatitis B (HBV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 36 Y | Male | Unknown | <-70°C | 03-Nov-12 | Viral Load | Not Available | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | Unknown | No | Unknown | HBsAG S/Co 719.39 (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect) | ||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107061121007DD | Hepatitis B (HBV) | Spain | 1.00 | 1.00 | $75.00 | 55 Y | Female | <-70°C | 10-Dec-07 | Roche cobas | 44 IU/mL | HBV Ct Value - 32 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (324) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott IMX) | |||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107062021108DD | Hepatitis B (HBV) | Spain | 1.00 | 2.00 | $75.00 | 23 Y | Female | <-70°C | 11-Feb-08 | Roche cobas | 750 IU/mL | HBV Ct Value - 33 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (475) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) | |||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107063052710DD | Hepatitis B (HBV) | Spain | 1.25 | 2.00 | $75.00 | 18 Y | Male | <-70°C | 27-May-10 | Roche cobas | 662 IU/mL | HBV Ct Value - 28 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (613) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107064021211DD | Hepatitis B (HBV) | Russia | 0.50 | 1.00 | $75.00 | 50 Y | Male | <-70°C | 12-Feb-11 | Roche cobas | 52 IU/mL | HBV Ct Value - 33 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (182) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107065122911DD | Hepatitis B (HBV) | Spain | 1.00 | 1.00 | $75.00 | 34 Y | Male | <-70°C | 29-Dec-11 | Roche cobas | 534 IU/mL | HBV Ct Value - 30 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (383) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107066021412DD | Hepatitis B (HBV) | Spain | 1.50 | 1.00 | $75.00 | 26 Y | Female | <-70°C | 14-Feb-12 | Roche cobas | 21 IU/mL | HBV Ct Value - 35 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (282) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107067030312DD | Hepatitis B (HBV) | Spain | 1.00 | 1.00 | $75.00 | 45 Y | Male | <-70°C | 03-Mar-12 | Roche cobas | <20 IU/mL | HBV Ct Value - 35 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | HBsAG S/Co (274) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | ||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107068050712DD | Hepatitis B (HBV) | Spain | 1.00 | 1.00 | $75.00 | 47 Y | Male | <-70°C | 07-May-12 | Roche cobas | <20 IU/mL | HBV Ct Value - 33 | Innogenetics INNO-LIPA | D | $75.00 | Unknown | Asymptomatic | N/A | N/A | N/A | N/A | HBsAG S/Co (248) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect) | |||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900018262012710DD | Hepatitis B (HBV) | France | 1.00 | 2.00 | $75.00 | <-70C | 27-Jan-10 | Roche cobas | >110,000,000 IU/mL | Gene S Sequencing In-house Assay | C | Enzyme immunoassay | adr | Serotype | $75.00 | Unknown | 384,000 ng/mL | 427.560 | 396.180 | 414.580 | 45.603 | Pos | HBc Positive, HBe Ag Positive | ||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900018263051611DD | Hepatitis B (HBV) | France | 1.00 | 3.00 | $75.00 | <-70C | 16-May-11 | Roche cobas | 2,414,382 IU/mL | Gene S Sequencing In-house Assay | B4 | Enzyme immunoassay | ayw1 | Serotype | $75.00 | Unknown | 3,000 ng/mL | 320.920 | 316.720 | 299.330 | 45.455 | HBc Positive, HBe Positive | Pos | ||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900018265090811DD | Hepatitis B (HBV) | France | 1.00 | 5.00 | $75.00 | <-70C | 08-Sep-11 | Roche cobas | 13,961,137 IU/mL | Gene S Sequencing In-house Assay | D1 | Enzyme immunoassay | ayw2 | Serotype | $75.00 | Unknown | HBc Positive, HBe Positive | 96,000 ng/mL | 494.03 | 50.847 | 49.180 | 50.847 | Pos | P120T | |||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900018267032312DD | Hepatitis B (HBV) | France | 1.00 | 1.00 | $75.00 | <-70C | 23-Mar-12 | Roche cobas | 7,199,505 IU/mL | Gene S Sequencing In-house Assay | E | Enzyme immunoassay | ayw4 | Serotype | $75.00 | Unknown | 12,000 ng/mL | 398.130 |413.990 | 406.520 | 46.154 | HBc Positive, HBe Positive | Pos | ||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900053608092210DD | Hepatitis B (HBV) | France | Citrated Plasma | 1.00 | 7.00 | $75.00 | Unknown | <-70C | 22-Sep-10 | Roche cobas | 2,811,723 IU/mL | Gene S Sequencing In-house Assay | D2 | Enzyme immunoassay | ayw2 | Serotype | $75.00 | Unknown | Hbc Positive, HBsAg Positive, HBe Positive | 96,000 ng/mL | 641.140 | 543.020 | 530.410 | Pos | 120.63 | ||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900053609051012DD | Hepatitis B (HBV) | France | Citrated Plasma | 1.00 | 4.00 | $75.00 | Unknown | <-70C | 10-May-12 | Roche cobas | 743,221 IU/mL | Gene S Sequencing In-house Assay | E | Enzyme immunoassay | ayw4 | Serotype | $75.00 | Unknown | 24,000 ng/mL | 366.990 | 329.940 | 322.800 | 44.118 | HBc Positive | Pos | ||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900053610060712DD | Hepatitis B (HBV) | France | Citrated Plasma | 1.00 | 3.00 | $75.00 | Unknown | <-70C | 07-Jun-12 | Roche cobas | 6,113 IU/mL | Gene S Sequencing In-house Assay | F1 | Enzyme immunoassay | adw4 | Serotype | $75.00 | Unknown | 48,000 ng/mL | 440.860 | 412.550 | 420.100 | 47.619 | HBc Positive, HBe Positive | Pos | ||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900053611082412DD | Hepatitis B (HBV) | France | Citrated Plasma | 1.00 | 8.00 | $75.00 | Unknown | <-70C | 24-Aug-12 | Roche cobas | 8,589,305 IU/mL | Gene S Sequencing In-house Assay | D2 | Enzyme immunoassay | ayw3 | Serotype | $75.00 | Unknown | HBc Positive | 192,000 ng/mL | 385.800 | 444.870 | 423.080 | 39.571 | Pos | ||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900053697110910DD | Hepatitis B (HBV) | France | Citrated Plasma | 1.00 | 8.00 | $75.00 | Unknown | <-70C | 09-Nov-10 | Roche cobas | >110,000,000 IU/mL | Gene S Sequencing In-house Assay | B2 | Enzyme immunoassay | adw2 | Serotype | $75.00 | Unknown | 384,000 ng/mL | 346.230 | 359.370 | 351.060 | 44.839 | Pos | HBc Positive, HBeAg Positive, | Pos | |||||||||||||||||||||||||||||||||||
| CIT0000-EQ900068510073011DD | Hepatitis B (HBV) | France | Citrated Plasma | 0.25 | 1.00 | $75.00 | Unknown | <-70°C | 30-Jul-11 | Roche cobas | 40,896 copies/mL | Gene S Sequencing In-house Assay | B4 | Immuno-Enzymatique | ayw1 | Serotype | $75.00 | Unknown | 274.86 | 57.365 | Pos | Pos | |||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900068513040609DD | Hepatitis B (HBV) | France | Citrated Plasma | 1.25 | 1.00 | $75.00 | Unknown | <-70°C | 06-Apr-09 | Roche cobas | 10 cps/mL | Gene S Sequencing In-house Assay | B2 | Immuno-Enzymatique | trop faible | Serotype | $75.00 | Unknown | 163.94 | 38.754 | Pos | ||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900068514060911DD | Hepatitis B (HBV) | France | Citrated Plasma | 1.00 | 2.00 | $75.00 | Unknown | <-70°C | 09-Jun-11 | Roche cobas | <6 cps/mL | Gene S Sequencing In-house Assay | B5 | Immuno-Enzymatique | trop faible | Serotype | $75.00 | Unknown | 32.348 | Pos | 56.39 | ||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900080435110119DD | Hepatitis B (HBV) | France | Citrated Plasma | 1.00 | 5.00 | $75.00 | Unknown | <-70C | 01-Nov-19 | Roche cobas | 1,543,655 IU/mL | Gene S Sequencing In-house Assay | D | Enzyme immunoassay | ayw2 | Serotype | $75.00 | Unknown | HBe Positive | 96,000 ng/mL | 552.060 | 515.640 | 522.470 | 50.847 | Pos | ||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083584042208DD | Hepatitis B (HBV) | France | 1.00 | 1.00 | $75.00 | < -70C | 22-Apr-08 | Roche cobas | 6 copies/mL | Gene S Sequencing In-house Assay | E | Immuno-Enzymatique | ayw4 | Serotype | $75.00 | Unknown | 326.1 | 55.556 | Pos | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083585071008DD | Hepatitis B (HBV) | France | 1.00 | 2.00 | $75.00 | < -70C | 10-Jul-08 | Roche cobas | <6 cps/mL | Gene S Sequencing In-house Assay | D3 | Immuno-Enzymatique | ayw3 | Serotype | $75.00 | Unknown | 382.21 | 54.545 | Pos | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083586051608DD | Hepatitis B (HBV) | France | 1.00 | 1.00 | $75.00 | < -70C | 16-May-08 | Roche cobas | 322 copies/mL | Gene S Sequencing In-house Assay | F | Immuno-Enzymatique | adw4 | Serotype | $75.00 | Unknown | 403.16 | 45.143 | Pos | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083587053008DD | Hepatitis B (HBV) | France | 1.00 | 1.00 | $75.00 | < -70C | 30-May-08 | Roche cobas | 7 copies/mL | Gene S Sequencing In-house Assay | A | Immuno-Enzymatique | adw2 | Serotype | $75.00 | Unknown | 341.19 | 54.545 | Pos | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083588052509DD | Hepatitis B (HBV) | France | 0.50 | 1.00 | $75.00 | < -70C | 25-May-09 | Roche cobas | 1,179 cps/mL | Gene S Sequencing In-house Assay | D | Immuno-Enzymatique | ayw2 | Serotype | $75.00 | Unknown | HBc IgM Negative | 656.06 | 43.246 | Pos | |||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083589101410DD | Hepatitis B (HBV) | France | 1.00 | 1.00 | $75.00 | < -70C | 14-Oct-10 | Roche cobas | 392 copies/mL | Gene S Sequencing In-house Assay | D2 | Immuno-Enzymatique | ayw2 | Serotype | $75.00 | Unknown | Ac HBs Positive - Ac Hbe Positive | 594.01 | 50 | Pos | |||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083590011111DD | Hepatitis B (HBV) | France | 1.00 | 1.00 | $75.00 | < -70C | 11-Jan-11 | Roche cobas | 33 copies/mL | Gene S Sequencing In-house Assay | D1 | Immuno-Enzymatique | ayw2 | Serotype | $75.00 | Unknown | HBc Positive | 420.07 | 56.727 | Pos | Pos | ||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083591110511DD | Hepatitis B (HBV) | France | 0.50 | 1.00 | $75.00 | < -70C | 05-Nov-11 | Roche cobas | 281 cps/mL | Gene S Sequencing In-house Assay | D | Immuno-Enzymatique | ayw2 | Serotype | $75.00 | Unknown | Ag Hbe Negative | 564.34 | 52.117 | Pos | Pos | ||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083592110411DD | Hepatitis B (HBV) | France | 1.00 | 2.00 | $75.00 | < -70C | 04-Nov-11 | Roche cobas | 79 copies/mL | Gene S Sequencing In-house Assay | A3 | Immuno-Enzymatique | ayw1 | Serotype | $75.00 | Unknown | 583.12 | 50847 | Pos | Pos | |||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083602050710DD | Hepatitis B (HBV) | France | 1.00 | 1.00 | $75.00 | <-70C | 07-May-10 | Roche cobas | >110,000,000 IU/mL | Gene S Sequencing In-house Assay | C2 | Enzyme immunoassay | adr | Serotype | $75.00 | Unknown | 384,000 ng/mL | 552.250 | 603.920 | 617.560 | 44.776 | Pos | HBc Positive, HBeAg Positive | ||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083603033012DD | Hepatitis B (HBV) | France | 1.00 | 1.00 | $75.00 | <-70C | 30-Mar-12 | Roche cobas | 1,069,373 IU/mL | Gene S Sequencing In-house Assay | C | Enzyme immunoassay | adr | Serotype | $75.00 | Unknown | 6,000 ng/mL | 284.630 | 242.390 | 245.800 | Pos | HBc Positive, HBeAg Positive | Pos | 53.615 | |||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083604100412DD | Hepatitis B (HBV) | France | 1.00 | 1.00 | $75.00 | <-70C | 04-Oct-12 | Roche cobas | 8,407,621 IU/mL | Gene S Sequencing In-house Assay | C | Enzyme immunoassay | adr | Serotype | $75.00 | Unknown | 3,000 ng/mL | 480.280 | 543.020 | 496.920 | Pos | HBc Positive, HBeAg Positive | Pos | 54698 | |||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900083606050312DD | Hepatitis B (HBV) | France | 1.00 | 5.00 | $75.00 | <-70C | 03-May-12 | Roche cobas | 88,167,700 IU/mL | Gene S Sequencing In-house Assay | D8 | Enzyme immunoassay | ayw2 | Serotype | $75.00 | Unknown | HBc Positive, HBeAg Positive | 192,000 ng/mL | 318.700 | 347.590 | 320.320 | 30.5 | Pos | Pos | |||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900097991082008DD | Hepatitis B (HBV) | France | 1.00 | 2.00 | $75.00 | < -70C | 20-Aug-08 | Roche cobas | 7 copies/mL | Gene S Sequencing In-house Assay | D | Immuno-Enzymatique | trop faible | Serotype | $75.00 | Unknown | HBc Positive | 37.852 | Pos | 9.973 | |||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900097992112508DD | Hepatitis B (HBV) | France | 1.25 | 1.00 | $75.00 | < -70C | 25-Nov-08 | Roche cobas | 24 cps/mL | Gene S Sequencing In-house Assay | F2 | Immuno-Enzymatique | adw4 | Serotype | $75.00 | Unknown | 739.3 | 95.4 | Pos | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900097993032608DD | Hepatitis B (HBV) | France | 1.00 | 2.00 | $75.00 | < -70C | 26-Mar-08 | Roche cobas | 674 copies/mL | Gene S Sequencing In-house Assay | A | Immuno-Enzymatique | ayw1 | Serotype | $75.00 | Unknown | 2.06 | 1.125 | Pos | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900105624061812DD | Hepatitis B (HBV) | France | 1.00 | 3.00 | $75.00 | 39 Y | Male | <-70C | 18-Jun-12 | Elisa | 0.053 | Genotype | D | $75.00 | Unknown | T118R Q129P | Not Tested | Positive | <6 UI/mL Viral Load | Negative | Positive | U/A | ||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900108436031811DD | Hepatitis B (HBV) | France | 1.00 | 12.00 | $75.00 | < -70C | 18-Mar-11 | Roche cobas | Not Available | Gene S Sequencing In-house Assay | E | Immuno-Enzymatique | NT | Seroype | $75.00 | Unknown | Pos | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900108445062308DD | Hepatitis B (HBV) | France | 0.50 | 1.00 | $75.00 | < -70C | 23-Jun-08 | Roche cobas | 19 cps/mL | Gene S Sequencing In-house Assay | D | Mutations: G130R S132Y | Immuno-Enzymatique | ayw2 | Serotype | $75.00 | Unknown | 391.49 | 50.8 | Pos | |||||||||||||||||||||||||||||||||||||||
| DSP3800-CJ900037056091112DD | Hepatitis B (HBV) | Italy | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 73 Y | Male | Non-Hispanic | <-70°C | 11-Sep-12 | Abbott Realtime PCR | 21,196 IU/mL | Siemens TruGene HCV | 1b | $200.00 | Unknown | Fatigue | ALT: 46; AST: 33; ALP: 44; LDH: 237; Bilirubin: 1.24; Serum Creatinine: 0.85 mg/dL; Chronic Hepatitis | No | No | Dental Care | anti-HCV+; anti-HBe+; HBeAg- (Abbott) | ||||||||||||||||||||||||||||||||||||
| DSP3800-CV900046269060613DD | Hepatitis B (HBV) | Vietnam | Double Spun Plasma | 1.00 | 3.00 | $200.00 | 24 Y | Male | Non-Hispanic | < -70C | 06-Jun-13 | Roche cobas | 71,800 IU/mL (HCV RNA); 195,000 (HBV RNA) | Real-Time PCR | 1 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice; Itching | ALT: 178; AST: 138; Bilirubin: 57.9 umol/L; Serum Creatinine: 69 umol/L; Hepatitis C & B | HBV+ | Partial | No | Unknown | HBsAg+; Anti HCV+ (ECLIA Cobas 6000) | |||||||||||||||||||||||||||||||||||
| DSP3800-EN900068512112713DD | Hepatitis B (HBV) | Italy | Double Spun Plasma | 1.00 | 1.00 | $200.00 | 58 Y | Male | Non-Hispanic | < -70C | 27-Nov-13 | Roche cobas | 8,820 IU/mL (HBV); 207,000 IU/mL (HCV) | PCR Sequencing; Siemens TruGene HCV | D (HBV); 1b (HCV) | $200.00 | Unknown | Fatigue | ALT: 81; AST: 37; LDH: 383; Bilirubin: 0.6; Serum Creatinine: 0.7 mg/dL; Grade 1 Stage 2; Chronic Active Hepatitis due to HBV & HCV | No | No | Sexual transmission | HBsAg+; HDV Ab-; HBsAb-; HCV Ab+ (CMIA) | ||||||||||||||||||||||||||||||||||||
| EDP0000-AI900076668091919DD | Hepatitis B (HBV) | USA | 1.00 | 1.00 | $75.00 | 30 Y | Female | <-70C | 19-Sep-19 | COBAS(R) AmpliPrep | TaqMan(R) HBV Test v2.0 | 2,377 IU/mL | HBV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AI900084088030717DD | Hepatitis B (HBV) | USA | 1.00 | 1.00 | $75.00 | 58 Y | Male | <-70C | 07-Mar-17 | Abbott Architect | Positive | HBV | $75.00 | Unknown | 03.16.17 | ||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AI900338354112219DD | Hepatitis B (HBV) | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 22-Nov-19 | COBAS(R) AmpliPrep | TaqMan(R) HBV Test v2.0 | 459,761,460 | HBV | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AI900342789101219DD | Hepatitis B (HBV) | K2 EDTA Plasma | 1.60 | 1.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 12-Oct-19 | COBAS(R) AmpliPrep | TaqMan(R) HBV Test v2.0 | 636 | HBV | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-CV900029052041718DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 4.00 | $200.00 | 29 Y | Female | Non-Hispanic | <-70C | 17-Apr-18 | Roche Cobas Taqman | 2,600 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; HBeAg + ; HBcIgG + | 30-Mar-2018 | 3-Apr-2018 | $200.00 | Unknown | Fatigue; Jaundice | 30-Mar-18 | ALT: 479 U/L | AST: 178 U/L | Bilirubin: 25.8 umol/L | Creatinine: 64 umol/L | Chronic Hepatitis B 10-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900029053041718DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 35 Y | Male | Non-Hispanic | <-70C | 17-Apr-18 | Roche Cobas Taqman | 170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; Anti HBcIgG + | 3-Apr-18 | $200.00 | Unknown | Fatigue | 3-Apr-18 | ALT: 1464 U/L | AST: 971 U/L | Bilirubin: 66 umol/L | Creatinine: 95 umol/L | Acute Hepatitis B 30-Mar-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900029055041718DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 5.00 | $200.00 | 27 Y | Female | Non-Hispanic | <-70C | 17-Apr-18 | Roche Cobas Taqman | 7,350 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; HBeAg + ; | 6-Apr-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 6-Apr-18 | ALT: 1045 U/L | AST: 2374 U/L | 6-Apr-2018 | Bilirubin: 91 umol/L | Creatinine: 52 umol/L | Acute Hepatitis B 4-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900029069042418DD | Hepatitis B (HBV) | Vietnam | 1.00 | 2.00 | $200.00 | 33 Y | Male | <-70C | 24-Apr-18 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; HBeAb + ; HBeAg - ; | 19-Apr-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 2012 | ALT: 48 U/L | AST: 34 U/L | Bilirubin: 4.9 umol/L | Creatinine: 85 umol/L | Chronic Hepatitis B 9-Apr-18 | None | ||||||||||||||||||||||||||||||||||||||
| EDP0000-CV900040658041718DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 4.00 | $200.00 | 51 Y | Female | Non-Hispanic | <-70C | 17-Apr-18 | Roche Cobas Taqman | 94,800,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; ;HBeAg - ;HBcIgG + ; Anti HBC + | 9-Apr-2018 | 12-Apr-2018 | $200.00 | Unknown | Decreased appetite; Fatigue | 9-Apr-18 | ALT: 1335 U/L | AST: 781 U/L | ALP: 150 U/L | Bilirubin: 51 umol/L | Creatinine: 55 umol/L | Acute Hepatitis B 10-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900040659011918DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 45 Y | Male | Non-Hispanic | <-70C | 19-Jan-18 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 9-Jan-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 9-Jan-18 | ALT: 300 U/L | AST: 673 U/L | ALP: 101 U/L | Bilirubin: 21.3 umol/L | Creatinine: 87 umol/L | Chronic Hepatitis B 9-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900040660031418DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 3.00 | $200.00 | 42 Y | Male | Non-Hispanic | <-70C | 14-Mar-18 | Roche Cobas Taqman | 4,210 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 9-Mar-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 2008 | ALT: 361 U/L | AST: 192 U/L | Bilirubin: 513 umol/L | Creatinine: 72 umol/L | Cirrhosis and Hepatitis B 6-Mar-18 | Cirrhosis | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900040671041718DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.25 | 4.00 | $200.00 | 37 Y | Male | Non-Hispanic | <-70C | 17-Apr-18 | Roche Cobas Taqman | 31,600,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 7-Apr-18 | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | 2014 | ALT: 317 U/L | AST: 139 U/L | Bilirubin: 163 umol/L | Creatinine: 102 umol/L | Chronic Hepatitis B 7-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900049295041918DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 60 Y | Male | Non-Hispanic | <-70C | 19-Apr-18 | Roche Cobas Taqman | 170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; HBeAg - ; HBcIgM - | 29-Mar-18 | $200.00 | Unknown | Fatigue | 10-Mar-18 | ALT: 877 U/L | AST: 1094 U/L | Bilirubin: 135 umol/L | Creatinine: 69 umol/L | Chronic Hepatitis B 13-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900049296042418DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 50 Y | Male | Non-Hispanic | <-70C | 24-Apr-18 | Roche Cobas Taqman | 1,020 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 16-Apr-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 2000 | ALT: 142 U/L | AST: 281 U/L | Bilirubin: 388 umol/L | Creatinine: 57 umol/L | Chronic Hepatitis B 2-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900049298042418DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 3.00 | $200.00 | 43 Y | Male | Non-Hispanic | <-70C | 24-Apr-18 | Roche Cobas Taqman | 3,020,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBeAb + ; HBeAg + HBc Total + ; HBcIgM - ; | 20-Apr-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 2011 | ALT: 1167 U/L | AST: 334 U/L | Bilirubin: 382 umol/L | Creatinine: 74 umol/L | Chronic Hepatitis B 1-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900049300041718DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 3.00 | $200.00 | 68 Y | Male | Non-Hispanic | <-70C | 17-Apr-18 | Roche Cobas Taqman | 168,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAb + ; 3-Apr-2018 ; Anti HBe + ; | 3-Apr-2018 | 9-Apr-2018 | $200.00 | Unknown | Decreased appetite; Fatigue | 3-Apr-18 | ALT: 70 U/L | AST: 109 U/L | Bilirubin: 39.6 umol/L | Creatinine: 96 umol/L | Chronic Hepatitis B 3-Apr-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900056408012618DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 3.00 | $200.00 | 59 Y | Male | Non-Hispanic | <-70C | 26-Jan-18 | Roche Cobas Taqman | 37,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 19-Jan-18 | $200.00 | Unknown | Abdominal pain; Fatigue | 2016 | ALT: 3350 U/L | AST: 1762 U/L | Bilirubin: 61.1 umol/L | Creatinine: 98 umol/L | Chronic Hepatitis B 19-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900062661011018DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 0.90 | 5.00 | $100.00 | 31 Y | Male | Non-Hispanic | <-70C | 10-Jan-18 | Roche Cobas Taqman | 313,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 2-Jan-18 | $100.00 | Unknown | Decreased appetite; Fatigue | 2-Jan-18 | ALT: 153 U/L | AST: 503 U/L | Bilirubin: 17.3 umol/L | Creatinine: 75 umol/L | Acute Hepatitis B 4-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900062662122717DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 1.00 | $200.00 | 35 Y | Female | Non-Hispanic | <-70C | 27-Dec-17 | Roche Cobas Taqman | 774,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 18-Dec-17 | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue | 18-Dec-17 | ALT: 110 U/L | AST: 322 U/L | Bilirubin: 25.7 umol/L | Creatinine: 72 umol/L | Acute Hepatitis B 18-Dec-17 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900062668122717DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 47 Y | Male | Non-Hispanic | <-70C | 27-Dec-17 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | None | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue | 1997 | ALT: 693 U/L | AST: 1084 U/L | Bilirubin: 16.5 umol/L | Creatinine: 94 umol/L | Chronic Hepatitis B 20-Dec-17 | None | |||||||||||||||||||||||||||||||||||||
| EDP0000-CV900062669080218DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 33 Y | Male | Non-Hispanic | <-70C | 02-Aug-18 | Roche Cobas Taqman | 4,170,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 28-Jun-18 | $200.00 | Unknown | Abdominal pain; Fatigue | 18-Jun | ALT: 537 U/L | AST: 107 U/L | Bilirubin: 13.2 umol/L | Creatinine: 62 umol/L | Chronic Hepatitis B 30-Jun-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900066836060518DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 42 Y | Male | Non-Hispanic | <-70C | 05-Jun-18 | Roche Cobas Taqman | 556,000 IU/mL | HBV DNA | Hepatitis Serology Result | HCV Ab + ; HBsAg + | 17-May-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 17-May-18 | ALT: 227 U/L | AST: 114 U/L | Bilirubin: 117 umol/L | Creatinine: 73 umol/L | Hepatitis B and C 25-May-18 | HCV Ab+ ; HCV RNA- | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900066840060418DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 55 Y | Male | Non-Hispanic | <-70C | 04-Jun-18 | Roche Cobas Taqman | 34,500,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + ; HBeAb + ; HBcTotal + ; | 28-May-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 25-May-18 | ALT: 683 U/L | AST: 241 U/L | Bilirubin: 39 umol/L | Creatinine: 68 umol/L | Chronic Hepatitis B 31-May-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900066841080318DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 4.00 | $200.00 | 59 Y | Male | Non-Hispanic | <-70C | 03-Aug-18 | Roche Cobas Taqman | 737,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 27-Jul-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 2014 | ALT: 54 U/L | AST: 105 U/L | Bilirubin: 71.4 umol/L | Creatinine: 179 umol/L | Chronic Hepatitis B 26-Jul-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900074039122917DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 5.00 | $200.00 | 73 Y | Male | Non-Hispanic | <-70C | 29-Dec-17 | Roche Cobas Taqman | 2,280 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 29-Dec-17 | $200.00 | Unknown | Decreased appetite; Fatigue | 18-Dec-17 | ALT: 100 U/L | AST: 75 U/L | Bilirubin: 18.3 umol/L | Creatinine: 72 umol/L | Hepatitis B 25-Dec-17 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900074040122717DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 1.00 | $200.00 | 34 Y | Male | Non-Hispanic | <-70C | 27-Dec-17 | Roche Cobas Taqman | 43,900 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 9-Nov-17 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 9-Nov-17 | ALT: 89 U/L | AST: 127 U/L | Bilirubin: 127 umol/L | Creatinine: 60 umol/L | Hepatitis B 26-Dec-17 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900074053080218DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 41 Y | Male | Non-Hispanic | <-70C | 02-Aug-18 | Roche Cobas Taqman | 3,250,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 13-Jul-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 13-Jul-18 | ALT: 138 U/L | AST: 25 U/L | Bilirubin: 200 umol/L | Creatinine: 67 umol/L | Chronic Hepatitis B 25-Jul-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900077905052518DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 28 Y | Male | Non-Hispanic | <-70C | 25-May-18 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBeAg +; HBeAb - | 23-May-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 2014 | ALT: 657 U/L | AST: 343 U/L | Bilirubin: 86 umol/L | Creatinine: 82 umol/L | Chronic Hepatitis B 21-May-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900077907060518DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 48 Y | Male | Non-Hispanic | <-70C | 05-Jun-18 | Roche Cobas Taqman | 4,180,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg +; HBcTotal + | 25-May-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 2013 | ALT: 73 U/L | AST: 66 U/L | Bilirubin: 70.4 umol/L | Creatinine: 69 umol/L | Chronic Hepatitis B 25-May-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900077909122717DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 4.00 | $200.00 | 34 Y | Male | Non-Hispanic | <-70C | 27-Dec-17 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 2003 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 2003 | ALT: 881 U/L | AST: 606 U/L | Bilirubin: 140.4 umol/L | Creatinine: 72 umol/L | Chronic Hepatitis B 22-Dec-17 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900103646060518DD | Hepatitis B (HBV) | Vietnam | 1.00 | 2.00 | $200.00 | 48 Y | Male | <-70C | 05-Jun-18 | Roche Cobas Taqman | 7,170,000,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 28-May-18 | $200.00 | Unknown | Decreased appetite; Fatigue | 2010 | ALT: 544 U/L | AST: 834 U/L | Bilirubin: 39 umol/L | Creatinine: 68 umol/L | Chronic Hepatitis B 28-May-18 | None | ||||||||||||||||||||||||||||||||||||||
| EDP0000-CV900103647011918DD | Hepatitis B (HBV) | Vietnam | K2 EDTA Plasma | 1.00 | 1.00 | $200.00 | 31 Y | Male | Non-Hispanic | <-70C | 19-Jan-18 | Roche Cobas Taqman | 22,400,000 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 15-Jan-18 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | 15-Jan-18 | ALT: 665 U/L | AST: 1710 U/L | ALP: 107 U/L | Bilirubin: 47.8 umol/L | Creatinine: 97 umol/L | Hepatitis B 15-Jan-18 | None | ||||||||||||||||||||||||||||||||||||
| EDP0000-CV900103648012618DD | Hepatitis B (HBV) | Vietnam | 1.00 | 2.00 | $200.00 | 37 Y | Male | <-70C | 26-Jan-18 | Roche Cobas Taqman | 18,100 IU/mL | HBV DNA | Hepatitis Serology Result | HBsAg + | 16-Jan-18 | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | 16-Jan-18 | ALT: 900 U/L | AST: 1500 U/L | Bilirubin: 328.7 umol/L | Creatinine: 80 umol/L | Chronic Hepatitis B 11-Jan-18 | None | ||||||||||||||||||||||||||||||||||||||
| LHP0000-AI900093192062519DD | Hepatitis B (HBV) | USA | 1.50 | 1.00 | $75.00 | 68 Y | Male | <-70C | 25-Jun-19 | COBAS(R) AmpliPrep | TaqMan(R) HBV Test v2.0 | 2,530,994 IU/mL | HBV | $75.00 | Unknown |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.